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Summary
Cordyceps sinensis (Berk.) Sacc. is one of the well-described fungi that has been used in
traditional Chinese medicine for over 700 years. Fungal mycelia contain some polysaccha-
rides that are responsible for their biological activity. C. sinensis has traditionally been cul-
tivated on the high Tibetan plateau as a parasitic fungus growing on caterpillars. How-
ever, currently it is being cultivated on some insects and in artificial media. This article
deals with the advances in the production, isolation and purification of Cordyceps poly-
saccharide (CP) in recent years, as well as the structure elucidation and pharmacological
action. The article also aims to provide some references for further application and exploi-
tation in the future.
Key words: Cordyceps polysaccharide, production and purification, structure elucidation, phar-
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Introduction
The fungi of genus Cordyceps belong to the family
Clavicipitaceae of the order Hypocreales. According to
Sung et al. (1), there are more than 350 species all over
the world described as Cordyceps, out of which about
120 species have been reported from China (2). Cordy-
ceps sinensis (Berk.) Sacc. is a fungal parasite on the lar-
vae of Lepidoptera. In late autumn, the fungus infects
the caterpillar and devours its host; in the early summer
of the following year, the grass-like fruiting body pro-
trudes from the ’head’ of the dead host. Because of this
particular life cycle, it is called ’winter-worm and sum-
mer-grass’ or ’worm-grass’ in China (3). Some Cordyceps
species are valuable medicinal fungi in traditional Chi-
nese medicine and have long been used as general ton-
ics and aphrodisiacs. However, they grow slowly and
only in high altitude areas, hence, the supply is inade-
quate to meet the demand. Moreover, as a result of the
immoderate exploitation, the resource of Cordyceps is in
severe danger.
The mycelia are cultured and the fruiting body is
used as a substitute for steroidogenesis although the key
mechanism of fungal infection is not clear (3). Recent
studies have revealed that the Cordyceps and its ana-
morph possess a variety of biologically active substan-
ces, such as polysaccharides, cordycepin, ergosterol, with
extensive pharmacological effects (4). Cordyceps polysac-
charides (CP), the richest group and most important in
the activity, possess great potential and are also known
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as an important tool for studying the development of
Cordyceps products. As a traditional Chinese medicine of
luxury, compared with other medicinal fungi, Cordyceps
and its anamorph have various and unique pharmaco-
logical effects, reflected in the biological types and phar-
macodynamic studies of Cordyceps polysaccharides. The
article deals with the recent advances in the polysaccha-
ride production from the mycelia and fruiting bodies of
Cordyceps cultured in the artificial medium. The purpose is
to provide some references for further application research.
Polysaccharide Content in
the Cultured Cordyceps
In nature, C. sinensis is produced at the Qinghai-Ti-
bet Plateau, above 3000 m altitude. Because of the geo-
graphical limit, the natural resources are limited and
very expensive. On the other hand, the cultivation is not
easy because it is difficult to form the stroma. However,
over a period of time, fermentation technique has been
developed successfully for the production of Cordyceps,
which provides a large quantity of mycelium for the study
of CP. The polysaccharide content of different Cordyceps
spp. varies, including monosaccharide composition, phys-
ical and chemical properties and biological activity.
Differences in CP content
As mentioned above, there is variation in the poly-
saccharide content of Cordyceps spp. Wang et al. (5) found
that polysaccharide content in the mycelia of C. sinensis
was 157.3 mg/g. Although, by comparison, the content
of total sugars between the corpus (part of the insect)
and fruiting body (ascoma) was slightly different (24.2
and 24.9 %, respectively), the content in mycelium was
higher (39.4 %) (6). By colorimetric assay using sulphu-
ric acid anthrone, Bai et al. (7) found that the content of
polysaccharides in C. sinensis and C. hawkesii (Gray) Co-
oke was 3.5 and 0.7 %, respectively, which was much
lower than in C. sinensis.
C. militaris (L. ex St. Amans) Link is considered as
the ideal Cordyceps sp. and can be cultivated well in sol-
id or liquid culture. Huang et al. (8) studied the nonvol-
atile components in the fruiting bodies and mycelia of
C. militaris and found that total sugars were 260.64 and
389.47 mg/g, respectively, but reducing sugar content of
the fruiting body was higher than that of mycelia. Wen
et al. (9) compared the polysaccharide content of the
silkworm Cordyceps fruiting body, stroma, sclerotium and
mycelium and found it the highest (86.49 mg/g) in the
fruiting body, followed by stroma and sclerotium. In the
artificial medium, the CP content in dry matter was 0.14 %
(10).
C. sobolifera, also known as chanhua, chanyongcao,
chanrong, etc. in China, has a refreshing and cooling ef-
fect, and is used as a relatively rare drug for improving
acuity of vision, fever reduction, detoxification, relieving
convulsion, and other purposes. However, little is known
about it. To find out the main active components and to
facilitate further development and utilization, Wen et al.
(11) studied the content of CP in C. sobolifera and found
it to be 94.88 mg/g, which was significantly higher than
in C. militaris (32.30 mg/g), but slightly lower than in C.
sinensis (125.68 mg/g).
C. gunnii, another species of the genus, is a large
Cordyceps hosted on Hepialidae larvae and was first re-
ported in 1983 by Liang (12). C. gunnii and its anamorphs
have rich bioactive substances. The polysaccharide has
unique pharmacological effects, and has good develop-
ment prospects and utilization value (12). Cultivation of
C. gunnii for different growth periods showed that the
accumulation of polysaccharide in the mycelia was slow,
which increased in the logarithmic growth phase and
was maximum at 28.2 mg/g. CP content evaluation in
stroma, parasited worm, whole teleomorph and mycelia
showed it to be maximum in mycelia, followed by stroma
(13,14).
Differences in CP under different cultural conditions
Generally, the CP content in the fruiting bodies is
low in any basic culture medium, which could be in-
creased through the optimization of medium composi-
tion and cultural conditions. This not only reduces the
cost, but also improves the economic efficiency. Studies
have also been carried out on the influence of microele-
ments on the biomass and polysaccharide content in the
fruiting body. Yang et al. (15) studied the effect of differ-
ent concentrations of lanthanum nitrate (La(NO3)3) on C.
brasiliensis mycelium growth and polysaccharide con-
tent. The results showed that a certain concentration of
La(NO3)3 could increase polysaccharide content. When
the concentration of La(NO3)3 was 0.3 g/L, the polysac-
charide content was the highest (24.21 mg/g, 1.59 times
more than the control). However, with the increase of
La(NO3)3 concentration, the polysaccharide content was
gradually reduced. When the concentration of La(NO3)3
was 0.5 g/L, the polysaccharide content was 15.01 mg/g
only. Yu and Qian (16) studied the effect of selenium on
the CP content in C. militaris and found that the supple-
mentation of Se resulted in 51.03 mg/g of CP, almost twice
more than that of control, i.e. without Se (26.71 mg/g).
Xiao et al. (17) investigated the optimal culture re-
quirements for mycelial growth and exopolysaccharide
production by C. jiangxiensis JXPJ 0109 in submerged
culture. The optimal temperature, initial pH and incuba-
tion period for exopolysaccharide production were 28 °C,
7.0 and 10 days, respectively. The effect of different me-
dium ingredients on the exopolysaccharide production
was in the order of yeast extract>maltose>tryptone>
glycerol>KH2PO4>CaCl2>MgSO4, and the optimal me-
dium contained (in g/L of distilled water): maltose
(food-grade) 20, glycerol 8, tryptone 5, yeast extract 10,
KH2PO4 1, and CaCl2 0.5. Under the optimal conditions,
the maximum exopolysaccharide and biomass produc-
tion were 3.5 and 14.5 g/L after 10 and 8 days of fer-
mentation, respectively (17).
Lu (18) optimized the CP production by single-fac-
tor and multi-factor design experiments and reported the
best production (10.11 mg/g) in a medium containing
(in %): sucrose 3, peptone 10, MgSO4·7H2O 0.5, K2HPO4
1.0, pH=7.5, fermented at 25 °C and 125 rpm for 5 days.
By the orthogonal experimental study of temperature, pH,
incubation time and medium composition on the poly-
saccharide production, the optimal conditions were 22 °C,
pH=6.0 and incubation time for 5 days with a medium
containing (in %): cornmeal 2, sucrose 5, yeast extract 0.03,
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NH4NO3 0.04, KNO3 0.08, MgSO4·7H2O 0.02, K2HPO4 0.04,
and FeSO4·7H2O 0.02, which yielded 170.3 mg of poly-
saccharide per 100 mL of broth (19). Xiao et al. (20) stud-
ied submerged cultural conditions for the production of
polysaccharide by C. pruinosa and found that the molas-
ses mixed with sugar, peanuts and vitamin B instead of
sucrose, beef extract and yeast extract, in 25-litre fermen-
tation tank for 54 h, shortened the fermentation time,
which would not only reduce the cost, but also reach
high polysaccharide production level (9.51 g/L). Hsieh
et al. (21) studied the production of polysaccharides by
C. sinensis by using response surface methodology. The
composition of optimized medium for polysaccharide pro-
duction calculated from the regression model of RSM was
(in %): sucrose 6.17, corn steep powder 0.53, (NH4)2HPO4
0.5, and KH2PO4 0.15 at pH=4.44, with a predicted maxi-
mum polysaccharide production of 3.17 g/L. Under the
experimental conditions with this medium, the maxi-
mum polysaccharide production was 3.05 and 3.21 g/L
in a shake flask and a 5-litre jar fermentor, respectively.
When the pH was controlled at a higher level such as
pH=5.0, both the cell growth and polysaccharide pro-
duction were inhibited. A low pH (2.85) was required
for maximum production of polysaccharides.
Isolation and Purification of the Polysaccharide
Isolation and purification
Several studies have been carried out on the isola-
tion and purification of polysaccharides from the fungal
mycelia. Sun et al. (22) studied the extraction conditions
of C. sinensis mycelia and found that the ratio of raw
material powder in a 300-mesh size and water of 1:2.5,
the extraction time of 24 h and pH of 7.5–8.0 were the
best. Ruan (23) found that the temperature was the most
important factor for the polysaccharide extraction, fol-
lowed by the pH. The best results were obtained when
extraction was carried out twice with 0.1 g of mycelium
powder in 20 mL of distilled water (pH=4.2) at 100 °C
for 70 min. Che et al. (24) also obtained similar results,
but with alcohol; the polysaccharide obtained was of
better quality and purity. Wang et al. (25) studied the
differences in extraction methods from C. militaris, such
as ultrasonic and water, ultrasonic and alcohol, and hot
water and reflux methods. An orthogonal experimental
design was used to study the effects of extraction tem-
perature and duration, number of extraction cycles and
water concentration. The results showed that a water ex-
traction temperature of 80 °C with three extraction cy-
cles, each for 90 min, was found to be the best. Shi et al.
(26), through the single factor and orthogonal experi-
ment, studied the effect of different extraction times, the
ratio of material and water, and the microwave power.
The results showed that C. militaris crude polysacchari-
de reached 10.97 % when extraction was done with wa-
ter and 80 % microwave power for 20 min.
In the traditional polysaccharide purification method,
alcohol is used for precipitation, which, however, also
precipitates the protein. In order to get rid of the pro-
tein, Liu et al. (27) used orthogonal experiments optimiz-
ing the factors such as the ratio of sample and the mix-
ture of chloroform and butanol, and the reaction time.
The results showed that the ratio of sample and the mix-
ture of chloroform and butanol 1:2.4 (by mass per vol-
ume); chloroform and butanol 1:0.2 (by volume), and the
reaction time of 5 min were the optimum conditions.
This resulted in the removal of 97 % of protein. Combi-
nation of trifluoromethyl, trichloroethane and Sevag meth-
od for protein removal resulted in the removal of 96.2 %
of protein (28).
Another study on polysaccharide extraction from C.
gunnii by orthogonal design showed that the optimum
extraction conditions were water at 70 °C for 2 h and
three extraction cycles. After concentration to 1/6 of the
volume, ethanol was added to reach the final concentra-
tion of 85 % and the precipitate was recovered by centrifu-
gation. This was washed three times with 95 % ethanol,
dried in vacuum and subjected to further purification by
column chromatography on DEAE-Sephadex A-25 and
Sephadex G-200, which resulted in four fractions. The
polysaccharide content was 13.9 % and at least one frac-
tion was a protein-bound polysaccharide (29). When C.
pruinosa mycelia were extracted with hot water, follow-
ed by precipitation of polysaccharide with alcohol, dial-
ysis and subjected to Sevag method, followed by cellu-
lose and Sephadex G-100 column chromatography, two
pure polysaccharides, PS1 and PS2, were obtained (30).
There are some other methods such as ion exchange
and gel chromatography described for the purification
of CP (31–33). Under normal circumstances, the more
purified CP could be expected by combining a variety of
methods with the repeated purification.
Monosaccharide composition and structure analysis
Wu et al. (34) isolated one polysaccharide from C.
sinensis, which contained D-Glc, D-Man, L-Ara and D-Gal
in a molar ratio of 8:90:1:1. The average molecular mass
was approx. 8.3·104 Da. Li et al. (31) purified one water
soluble polysaccharide from C. sinensis mycelia with mo-
lecular mass of 210 kDa and its monosaccharide compo-
sition was glucose/mannose/galactose=1:0.6:0.75. Wu et al.
(35) isolated a polysaccharide with molecular mass of
about 7.7·103 Da from Cordyceps mycelia, with mannose/
galactose=1:9. After chemical analysis, IR, NMR spec-
troscopy and a-D-amylase digestion, it was identified as
a-D-glucan with a skeleton of 1®4 and 1®3 connections,
a-D-(1®6)-mannose skeleton through a-(1®3)-galactose
residues of O-6 bond linking. In addition, the mycelium of
C. sinensis contained a D-glucan. Methylation, Smith degra-
dation, acetolysis, NMR spectroscopy (1H, 13C, 13C–1H 2D
COSY) and acid hydrolysis studies were conducted to
elucidate its structure. The results indicated that D-glu-
can consisted of a backbone composed of (1®4)-D-glucosyl
residues and carried a single (1®6)-linked D-glucosyl re-
sidue. a-D-glucosidic linkages were present in the poly-
saccharide according to IR and NMR spectra. D-glucan
with iodine gave a faint blue colour, indicating the poly-
saccharide of a-(1®4) linkage with short and exterior
chains (35). A neutral mannoglucan with a molecular mass
of approx. 7.7·103 Da was obtained from C. sinensis my-
celium. It consisted of Man and Glc units in the molar
ratio of 1:9. A combination of chemical analysis, NMR
and IR spectroscopy together with digestion with a-D-
-amylase showed to have an a-D-glucan backbone with
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(1®4)- and (1®3)-linkages, and the side chains of a-D-
(1®6)-Man were attached to the backbone via O-6 of a-
(1®3)-Glc residues (36).
Kiho et al. (37) obtained a water-soluble, protein-
-containing galactomannan polysaccharide from C. sin-
ensis, with molecular mass of about 23 000 Da, consisting
mainly of D-mannose and D-galactose in the ratio of 3:5.
The polysaccharide had a highly branched structure, it
contained rhamnose, fructose, D-xylose, D-mannose, D-ga-
lactose and D-glucose, and was composed of (1®6)- and
(1®2)-linked a-D-mannopyranosyl residues in the main
chain. It possessed a large proportion of (1®5)-linked
b-D-galactofuranosyl residues and a small proportion of
(1®6)-linked a-D-galactopyranosyl residues.
Wang et al. (38) extracted a water-soluble polysac-
charide from artificially cultivated C. militaris fruiting
body. GC analysis showed the presence of Gal, Man, Glc
and GlcA, with the ratio of 1.00:1.58:7.89:0.19. The mo-
lecular mass of the purified polysaccharide was about
60 000 Da. It was gray and white powder-like substance
and contained monosaccharides in molar ratio of Gal/
Man/Glc=1.00:1.38:5.10, with less branching structure.
The main chain consisted of Gal, Man and Glc. Part of
(1®4) Glc constituted the branches at the third position.
The non-branched (1®4) Glc existed possibly with other
monosaccharides. Mannose connected as 1®6-linked and
Gal as 1®4-linked with the branch at the sixth position.
Yu et al. (32) isolated three polysaccharides from C. mili-
taris denoted as CPS-1, CPS-2 and CPS-3. The spectral
analysis of CPS-1 showed that its monosaccharides were
rhamnose, xylose, mannose, glucose and galactose in a
ratio of 1:6.43:25.6:16.0:13.8, which was a kind of (1®2)-
-connected mannose, (1®4)-connected xylose, (1®2) or
(1®3) rhamnose connected with galactose in the b-con-
figuration. CPS-2 contained glucose, xylose and galac-
tose (1:4.46:2.43) with glucoside bond in an a-configura-
tion. CPS-3 contained glucose with a-glucoside bond. The
main chain had (1®4) glucoside bond and every eighth
glucoside had an a-(1®6) glucoside bond branch (33).
Yang et al. (39) obtained six polysaccharides from
the cultured C. militaris. After purification by chroma-
tography on DEAE-cellulose 52 and Sephacryl S-100 HR
columns, three polysaccharide fractions were obtained:
P50-1, P70-1, and P70-2. Their structural features were
investigated by a combination of chemical and instru-
mental analyses, such as partial acid hydrolysis, methyl-
ation analysis, periodate oxidation (Smith degradation),
GC–MS, 13C NMR, HPAEC-PAD, and FT-IR. The results
indicated that P70-1 had a backbone of (1®6)-linked b-
-D-mannopyranosyl residues, which occasionally branch-
ed at O-3. The branches were mainly composed of
(1®4)-linked a-D-glucopyranosyl and (1®6)-linked b-
-D-galactopyranosyl residues, and terminated with b-D-
-galactopyranosyl and a-D-glucopyranosyl residues (40).
Yamada et al. (41) isolated a water-insoluble extra-
cellular glucan from C. ophioglossoides. The average mo-
lecular mass was about 632 000 Da. It was composed of
a backbone of (1®3)-linked b-D-glucopyranosyl residues
with a b-D-glucopyranosyl group attached to the O-6 of
every other D-glucopyranosyl residue of the backbone.
Using a-naphthylamine derivatives for capillary zone
electrophoresis analysis, it was determined that the my-
celia of C. kyushuensis polysaccharide consist mainly of
glucose, mannose, galactose and a small amount of ara-
binose (42).
Kiho et al. (43) isolated two protein-containing gal-
actomannans, CI-P and CI-A, from C. cicadae, both of
which contained D-mannose and D-galactose in the re-
spective proportions of 1:0.85 and 1:0.57. Analyses by
methylation, Smith degradation, gradual hydrolysis and
13C NMR chromatography showed that both were high-
ly branched with the main chain of (1®6) a-D-mannose
and the majority of the residues were replaced by a- or
b-D-galactose, or furan (1®2) a-D-mannose. Ukai et al.
(44) isolated a water-soluble galactomannan from C. ci-
cadae, which had a molecular mass of 27 000 Da, with
D-mannose and D-galactose in the ratio of 4:3. The sugar
had a high degree of branching, containing a-D-(1®2)
and a-D-(1®6) D-mannose connected residues. Ohta et al.
(45) isolated an acidic polysaccharide (APS) from C. mili-
taris. Analyses of sugar composition showed that APS
consisted of D-galactose, L-arabinose, D-xylose, L-rham-
nose and D-galacturonic acid.
Other aspects
Atomic force microscopy (AFM) is a powerful tool
for studying the material surface morphology and sur-
face processing. It has been broadly applied in biological
morphology, but rarely reported in polysaccharide ap-
plication. Cai et al. (46) directly observed the topography
of Cordyceps polysaccharides by AFM. The results showed
that its polysaccharide had a multi-branched structure
and a variety of different linkages between the adjacent
monosaccharides, which formed small rings or helical
structure.
Pharmacological Effects of the CP
Toxicological experiments
For health products or medicinal resources, CP needs
to be tested toxicologically. There are some studies deal-
ing with the acute and subchronic toxicity of the CP in
the solution, following the guidelines of the PR China
national standard ’Process and Methods of Food Secu-
rity and Toxicological Estimation’. Some indicators have
been examined, such as animal mass, biochemical prop-
erties of blood, and histopathological changes of liver
and kidney. The results show that extract from C. sin-
ensis is not toxic. It also decreased the mouse sperm ab-
normality rate (47,48). Studies on acute toxicity, bone
marrow chromosome aberrations and Ames test showed
that the C. sinensis powder was safe (48). Chen et al. (49)
studied the polysaccharide fraction of C. sinensis (PSCS)
and investigated its effect on the proliferation and dif-
ferentiation of human leukemic U937 cells using an in
vitro culture system. The results showed that the condi-
tioned medium from PSCS (10 mg/mL) stimulated blood
mononuclear cells (PSCS-MNC-CM) that significantly
inhibited the proliferation of U937 cells, which resulted
in a growth inhibition rate of 83.1 % when treated for 5
days, but higher concentrations of the medium did not
enhance the growth inhibition further.
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Antitumour activity
Yang et al. (50) studied the effect of exopolysaccha-
ride fraction (EPSF) of C. sinensis on c-Myc, c-Fos, and
vascular endothelial growth factor (VEGF) expression of
tumour-bearing mice. The mice (C57BL/6) were inocu-
lated with B16 melanoma cells through their tail veins
and administered three different doses of EPSF perito-
neally every two days for 27 days (total 14 doses). Sec-
tions from mouse paraffin-embedded liver and lung tis-
sues were subjected to immuno-histochemical analyses.
The results of c-Myc, c-Fos, and VEGF expression were
analyzed using Simple PCI image analysis software. The
c-Myc, c-Fos, and VEGF levels in the lungs and liver of
EPSF-treated mice were significantly lower than those of
untreated mice (p<0.05). This suggested that EPSF inhib-
ited tumour growth in the lungs and liver of mice, and
that it can be a potential adjuvant in cancer therapy (50).
Zhang et al. (51) isolated an EPSF from C. sinensis and
studied its effects on B16 melanoma-bearing mice. Three
doses of EPSF were administered intra-peritoneally eve-
ry two days after the day of tumour cell injection. The
experiment was terminated on day 28 and phagocytosis
of peritoneal macrophages and proliferation of spleen
and thymus lymphocytes were assayed. Also, tumour
metastatic foci on the lung and liver surface were check-
ed. The results showed that EPSF significantly enhanced
the Neutral Red uptake capacity of peritoneal macro-
phages (60 mg/kg, p<0.01; 120 mg/kg, p<0.001) and
spleen lymphocyte proliferation (60 mg/kg, p<0.05; 120
mg/kg, p<0.001) in B16-bearing mouse. The metastasis
of B16 melanoma cells to lungs (120 mg/kg) and liver
(30, 60 and 120 mg/kg) was significantly inhibited by
EPSF. Moreover, EPSF decreased the levels of Bcl-2 in
the lungs (120 mg/kg) and liver (30, 60 and 120 mg/kg).
These results suggested that EPSF had immunomodu-
latory function and antitumour activity (51).
Immune activity
The majority of studies of pharmacological effects of
CP are about their nonimmune activity. The pharmaco-
dynamics of immune activity of different fractions of CP
was evaluated by the mass of thymus and spleen of
mice injected intra-peritoneally and calculating the vis-
cera index. The results show that different C. sinensis poly-
saccharides enhance the phagocytic function of mono-
cytes and macrophages, and increase the mass of thymus
and spleen of mice that was inhibited by dexamethasone.
The effects of some fractions of CP on the viscera index
are not clear. However, the results show that different
fractions of CP enhance the immune response, spleen in-
dex, thymus index and the phagocytic function of mono-
cytes and macrophages (52). Liu and Fei (53) found that
C. pruinosa and C. taii polysaccharides (CPP1) enhance
cellular immune functions in vitro. The appropriate con-
centration increases spleen cytotoxic T-cell lymphocyte
(CTL) activity and M-phagocytosis in normal mice and
immunoinhibited mice. Gong et al. (54) studied the spe-
cific and non-specific immune functions using the car-
bon clearance test, hemolysin test and dinitrofluoroben-
zene-induced delayed type hypersensitivity test (DTH)
and found that CP enhanced the cellular and humoral
immunity. The immunomodulatory activity of polysac-
charides prepared from C. sinensis BCRC36421 under
submerged culture was investigated in human periph-
eral blood (55). The results demonstrated that fraction A
(exopolysaccharides, approx. 0.1 mg/mL) induced the
production of tumour necrosis factor alpha (TNF-a),
interleukin (IL)-6, and IL-10 dose-dependently. Even its
concentration of 0.025 mg/mL significantly augmented
the surface expression of CD11b in monocytes and poly-
morphonuclear neutrophils. Functional assay revealed that
fraction A (0.05 mg/mL) also elevated the phagocytosis
in monocytes and polymorphonuclear neutrophils (PMN).
On the other hand, fraction B (intracellular polysaccha-
rides) only moderately induced the TNF-a release, CD11b
expression, and phagocytosis at the same concentrations.
It was concluded that the immunomodulatory compo-
nents of C. sinensis under submerged culture were main-
ly in the culture filtrate (55).
In addition to CP, its depolymerizing substance also
has immune activity. Xiao et al. (56) found that the poly-
saccharide polymer solution significantly improved the
immunological activity in comparison with CP, provid-
ing a new direction for further research and development.
The CP can also enhance disease resistance of shrimp
when used as feed additive. Chang et al. (57) observed
the prawn hemolymph phagocytic activity in serum, bac-
teriolytic activity and phenol oxidase activity in prawns
fed with the diet containing 1 % CP. The results show
that CP significantly enhances prawn immune defense
ability. With the intraperitoneal injection of different doses
of CP in shrimp, the serum lysozyme and the phospha-
tase activity decreased significantly and the disease con-
trol was more effective (58).
Liver protective effect
Li et al. (59) studied the mechanism of CP resistance
to liver fibrosis using dimethyl-induced rat model of
liver fibrosis. The results indicate that the CP improved
the hepatic function (ALT, AST, Alb and Tbil) in com-
parison with the control group. There was a significant
decrease in malondialdehyde (MDA) content in CP group,
but superoxide dismutase (SOD) in CP group was mark-
edly increased. Compared to those of normal control
group, Hyp content, collagen IV content and TIMMP-2
level in liver tissue of the control group increased signif-
icantly, while the MMP-2 activity decreased. The appli-
cation of CP decreased these pathological indications at
different degrees. CP exerted rather good activity against
liver fibrosis with the activity related to the improvement
of degradation of the deposited collagens and anti-lipid
peroxidation.
CCL4 and D-GalN for acute liver injury and BCG+
LPS, BCG+LPS-induced autoimmune liver injury in mice
were previously used (60,61). Results showed that C.
gunnii polysaccharide, when administered at different
doses to mice, could significantly decrease the elevated
serum AIT and AST levels, inhibit the liver homogenate
in the MDA levels and increase TNF-a, IL-1 and the ac-
tivity of SOD. The pathological examination showed that
CP had significantly protective role against chemical liv-
er injury and autoimmune liver injury. CP has certain
anti-fibrotic effects on bovine serum albumin autoim-
mune liver injury (60,61). Its mechanism is related to the
increase in liver Kupffer cell function, reducing the im-
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mune complex deposition in the liver and non-specific
inflammatory response (62). Yang et al. (63) found that
CP and liver fibrosis might be related to the inhibition
of Smad2/3 and the promotion of Smad7 expression. In
addition, CP had a strong inhibitory effect on rat hepatic
stellate cells, cell proliferation and collagen synthesis,
which could be related to the inhibition of NF-kB activ-
ity and reduction of tumour necrosis factor, the expres-
sion of TNF-a and lowering the level of protein (64). C.
gunnii polysaccharides in Sprague-Dawley (SD) rat’s non-
-alcoholic steatohepatitis (NASH) might be related to the
prevention of anti-lipid peroxidation, inhibition of the
produced TNF-a, the regulation of leptin, insulin levels
and the protective effects of the mitochondria (65). In
addition, CP liposomes also have liver protective effect.
Pharmacological studies have shown that CP liposomes
could be achieved by increasing the cells or phagocytic
activity of Kupffer cells, speeding up the removal of toxic
substances, thereby inhibiting the synthesis of TGF-b1 so
as to achieve the role of anti-fibrosis (66).
Hypolipidemic effect
CP extracted from Paecilomyces hepialid (anamorphous)
in rat experiment was effective in reducing the blood
lipids and helping to protect the heart and liver. The to-
tal cholesterol (TC) and triglyceride (TG) levels in rats
given the test agent were markedly lower than those of
the rats in the control group, and their high-density li-
poprotein cholesterol (HDL-C) levels were higher than
those of the control group (67). Studies by Kim and Yun
(68) showed that polysaccharides from C. sinensis and C.
militaris have hypoglycemic effects.
Antimutagenic effect
During the metaphase/anaphase transition of mito-
sis (cell division), a micronucleus (MN) is formed. It
may arise from a whole lagging chromosome (aneugenic
event leading to chromosome loss) or an acentric chro-
mosome fragment detaching from a chromosome after
breakage (clastogenic event) which does not integrate in
the daughter nuclei. Its frequency reflects the cell ge-
netic material damage or the regulation. CP has rarely
been studied for inhibiting the mutagenesis. Chen et al.
(69,70) found that C. militaris polysaccharides had marked
dose-response relationship on mitomycin C (MMC) and
cyclophosphamide-induced inhibition of micronuclei. The
increase in CP dose resulted in the reduction of micro-
nuclei and the maximum inhibition rate on micronuclei
was 60.48 %.
Hypoglycemic effect
Kiho et al. (71) reported that the polysaccharide CS-
-F30 obtained from the mycelium of C. sinensis showed
potent hypoglycemic activity in genetically diabetic mice
after intraperitoneal administration, and the plasma glu-
cose level was quickly reduced in normal and streptozo-
tocin-induced diabetic mice after intravenous administra-
tion. Administration of CS-F30 to normal mice signifi-
cantly increased the activities of hepatic glucokinase,
hexokinase and glucose-6-phosphate dehydrogenase, al-
though the glycogen content in the liver was reduced.
Furthermore, CS-F30 lowered the plasma triglyceride
level and cholesterol level in mice. CP had no significant
impact on blood sugar levels in normal mice, but could
significantly reduce alloxan-induced diabetic blood sug-
ar levels in mice and had a better hypoglycemic action.
One of its hypoglycemic mechanisms is the promotion
of insulin resistance in adipose tissue glucose uptake (72).
Li et al. (73) found that CSP-1 decreased the blood glu-
cose levels to 200 mg/kg in 7 days of administration in
streptozotocin (STZ) and alloxan-induced diabetic rats,
and serum insulin levels were significantly increased. Its
mechanism promotes the progressive insulin release by
CP and insulin metabolism reduced. Gong (74) observed
that CP regulates the immune system and goes through
cytokines against free radical oxidation to achieve hypo-
glycemic effect.
Antioxidative activity
Chen et al. (75) studied the polysaccharide (PS) ex-
tracted from C. sinensis and its antioxidant activity on
H22-bearing mice. H22 cells were hypodermically inject-
ed into the right oxter of each mouse after the ICR mice
were treated with PS by means of gavage for 7 days.
The same administration process continued for 9 days.
At the end of the experiments, the tumour mass in each
mouse was measured. Superoxide dismutase (SOD) ac-
tivity and malondialdehyde (MDA) level in mouse liver,
brain and serum, and glutathione peroxidase (GSH-Px)
activity in mouse liver and brain were assayed. The re-
sults showed that the H22 tumour growth was signifi-
cantly inhibited by PS. Moreover, PS significantly enhanc-
ed the SOD activity of liver, brain and serum as well as
GSH-Px activity of liver and brain in tumour-bearing mice.
PS also significantly reduced the level of MDA in liver
and brain of tumour-bearing mice. Li et al. (31) reported
that the polysaccharide from C. sinensis with molecular
mass of 210 kDa showed strong antioxidative activity in
the cultured rat pheochromocytoma PC12 cells against
hydrogen peroxide (H2O2)-induced insult. The treatment
of the cells with the polysaccharide at 100 μg/mL prior
to H2O2 exposure significantly elevated the survival of
PC12 cells in the culture by over 60 %. In parallel, the
H2O2-induced production of malondialdehyde in the cul-
tured cells was markedly reduced by the polysaccharide
treatment. Moreover, the pretreatment of the isolated poly-
saccharide significantly attenuated the changes of gluta-
thione peroxidase and superoxide dismutase activities in
H2O2-treated cells in a dose-dependent manner. This
was the first report on identifying a polysaccharide from
Cordyceps, which protects against the free radical-in-
duced neuronal cell toxicity.
In addition to the above pharmacological effects, CP
also has other drug activities. Li et al. (76) compared the
effect of 14 kinds of CP on the lifespan of Drosophila
melanogaster and found that CP had very notable effects
against the senescence, among which two polysaccha-
rides had the best effects. Tong et al. (77) found that CP
enhanced the polysaccharide leukemia, the antigen-pre-
senting function of dendritic cells (DC), enhanced T-cell
recognition and destruction of tumour cells, combining
CP and DC. The immune therapy for leukemia provided
a basis for exploring new ways of treating leukemia (78).
Cordyceps, Paecilomyces tenuipes and Phytocordyceps sp. are
biocompatible and inducers of high levels of IL-8, and can
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serve as a potential wound caring material (79). Through
mice in vivo and in vitro testosterone, it was found that
CP contributes to an alternative medicine for the treat-
ment of some reproductive problems caused by insuffi-
cient testosterone levels in human males (75).
Ohta et al. (45) administered intranasally the APS to
mice and showed that it decreased virus titers in the
bronchoalveolar lavage fluid and the lung of mice in-
fected with influenza A virus, and increased the survival
rate. Furthermore, APS increased TNF-a and IFN-g levels
in mice when compared with those of untreated mice.
APS enhanced nitric oxide (NO) production and induc-
ed iNOS mRNA and protein expressions in RAW 264.7
murine macrophage cells. The induction of mRNA ex-
pression of cytokines including IL-1b, IL-6, IL-10 and
TNF-a was also observed. These results demonstrate
that APS has beneficial therapeutic effects against influ-
enza A virus infection, at least in part by modulation of
the immune function of macrophages (45).
Conclusions
Traditionally, Cordyceps has been eployed for poten-
tial benefits to the heart and respiration, for its energy-
-boosting effects and for anti-aging purposes. In human
cardiovascular studies, the use of Cordyceps lowered the
serum triglycerides and cholesterol, and increased the
beneficial HDL levels. Cordyceps enhances the nutritional
blood supply to the organs and extremities, specifically
increases the blood supply to the brain and defends the
heart against stress. Cordyceps boosts the respiration and
the body’s use of oxygen and helps in the treatment of
chronic bronchitis. It also possesses antioxidants which
retard the cellular destruction and demonstrates anti-in-
flammatory activity. It helps to protect the liver and kid-
neys against the damage. In a number of competitive
events, winning Chinese athletes have attributed their
high performance in part to the regular use of Cordyceps.
Their competitive success has led to the investigation of
Cordyceps for energy, endurance and stamina. The analy-
sis of Cordyceps has revealed the presence of natural sub-
stances which boost the immunity, increase stamina, and
improve recovery from fatigue. Results of various stud-
ies have shown that Cordyceps enhances the performan-
ce. In elderly patients, Cordyceps improved the quality of
a number of life parameters, including general physical
condition, mental health, appetite, vitality, sexual drive
and cardiac function. In effect, Cordyceps helps to turn
back the aging clock. Remarkably, no down-side or side-
-effects are known for Cordyceps. To the question if there
is an all-around supplementary super agent, Cordyceps
apparently has the ample evidence and the answer is yes.
It is evident that CP is effective in repairing immune
system, liver protection, hypoglycemic and hypolipide-
mic effects, and as antitumour agent. Fermentation is a
good technique for the production of CP. However, only
a few of Cordyceps species have received attention and
more studies are needed to maximize its social and eco-
nomic benefits.
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